Skip to search formSkip to main contentSkip to account menu

myricitrin

Known as: 3,3',4',5,5',7-hexahydroxyflavone 3-rhamnoside 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background and purpose: Multiple sclerosis (MS) as an autoimmune disease is the most common demyelinating inflammatory disease in… 
2017
2017
There is growing interest in the use of plant bioresources for managing Type 2 diabetes. In this study, Rhodamnia cinerea, which… 
2016
2016
  • 2016
  • Corpus ID: 52205747
Diabetes mellitus is a global health condition reaching epidemic proportions. One of the treatments for type 2 diabetes, acarbose… 
2015
2015
Introduction: Juvenile, adult vegetative, and reproductive phases are the three ontogenetic stages of flowering plants. Besides… 
2011
2011
本发明公开了杨梅苷在制备用于治疗心血管疾病药物中的应用,属医药技术领域。 本发明所述心血管疾病包括急性心肌缺血性冠心病、心脏缺血再灌注损伤、高脂血症、保护血管内皮细胞损伤。 本发明所述用于治疗心血管疾病的药物可由杨梅苷与一种或多种药学上可接受的载体或赋形剂制成药物组合物。 
2011
2011
本发明公开了一种杨梅苷及其药物组合物的制备方法。 本发明所述杨梅苷的制备方法包括使用有机溶剂从富含杨梅苷的植物中提取粗提物,粗提物用色谱方法分离、纯化,得到杨梅苷单体等步骤,该方法避免了常规柱层析的死吸附,保证整个分离过程在较低温度下进行,对于温度、光照、酸碱等不稳定中药化学成分的分离具有独特的优势,分离使用的流动相多数为水相,仅含少量的有机溶剂,既降低了实验成本,又降低了毒性溶剂的使用,对操作者的身体健康和环境的保护都具有重要意义。 制备得到的杨梅苷与药学上可接受的载体或赋形剂可制成各种剂型的药物。 
2010
2010
Objective:to inspect the degradation rate and half-life of elimination and study the pharmacokinetics of myricitrin liposome in… 
2009
2009
【Phytochemical investigation of Metasequoia glyptostroboids leaves resulted in the isolation of ten compounds. The structures… 
2008
2008
PURPOSE: A cosmetic composition containing quercitrin and/or myricitrin is provided to promote protein synthesis and collagen…